1,3-dipropyl-8-cyclopentylxanthine has been researched along with Diaphragmatic Paralysis in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Minic, Z | 1 |
| Zhang, Y | 1 |
| Mao, G | 1 |
| Goshgarian, HG | 1 |
| James, E | 1 |
| Nantwi, KD | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Diaphragmatic Paralysis
| Article | Year |
|---|---|
Transporter Protein-Coupled DPCPX Nanoconjugates Induce Diaphragmatic Recovery after SCI by Blocking Adenosine A1 Receptors.
Topics: Adenosine A1 Receptor Antagonists; Animals; Diaphragm; Male; Muscle Strength; Nanoconjugates; Rats; | 2016 |
Involvement of peripheral adenosine A2 receptors in adenosine A1 receptor-mediated recovery of respiratory motor function after upper cervical spinal cord hemisection.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor | 2006 |